Presentation at the ICS 2023

Presentation at the International Continence Society in Toronto, September 27^th-29^th, 2023.

Julien Ratelade from EG427 presented the results of a project performed in collaboration with Pelvipharm:
” Intravesical administration of EG110A, a novel nonreplicative Herpes Simplex Virus (HSV-1)-derived vector expressing the light chain of botulinum toxin F, inhibits C-type fibers in an acute intravesical capsaicin rat model ”
Ratelade J¹, Faugeroux J², Behr-Roussel D², Epstein A¹, Denys P³, Giuliano F³, Haag-Molkenteller C¹, Salot S¹.
1. EG427, 2. Pelvipharm, 3. Université Versailles Saint-Quentin/Paris Saclay/Faculty of Medicine, Neuro-uro-andrology R. Poincaré academic hospital/APHP,